Yuehong Wang - Concepedia

Author

Yuehong Wang

University of Illinois Chicago ORCID

Also Known As

Wang, Yuehong, YUE-HONG WANG, YUEHONG WANG, Yue-Hong Wang, Yue-hong WANG, Yue-hong Wang, Yuehong Wang, Yuehong Wang

126

Publications

3.4K

Citations

H-Index

109

Concepts

All Affiliations

University of Illinois Chicago Harbin Medical University University of Arizona Nankai University TB Alliance

About

Yuehong Wang is an author at University of Illinois Chicago specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	29	1.7K
2	Natural Sciences	12	14	772
3	Engineering	4	4	94
4	Health Sciences	4	4	258
5	Allergy	1	1	40

Yuehong Wang

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Structure−Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and Nonreplicating<i>Mycobacterium tuberculosis</i> Annamaria Lilienkampf, Jialin Mao, Baojie Wan, Journal of Medicinal Chemistry	2009	301
Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents Bo Zhou, Yantao He, Xian Zhang, Proceedings of the National Academy of Sciences Innate Immune SystemImmunologyImmunologic MechanismInnate ImmunityAntituberculosis Agents	2010	240
Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis Wěi Li, Ashutosh Upadhyay‬, Fabio L. Fontes, Antimicrobial Agents and Chemotherapy ImmunologyAntimicrobial ChemotherapyDrug ResistanceMycolic AcidsOuter Membrane	2014	198
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase Andrés Palencia, Xianfeng Li, Wei Bu, Antimicrobial Agents and Chemotherapy Drug TargetMolecular BiologyAntimicrobial ChemotherapyProtein SynthesisDrug Resistance	2016	116
Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus Mary Choules, Nina M. Wolf, Hyun Lee, Antimicrobial Agents and Chemotherapy	2019	114
Synthesis and Structure–Activity Relationships of Varied Ether Linker Analogues of the Antitubercular Drug (6<i>S</i>)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824) Andrew M. Thompson, Hamish S. Sutherland, Brian D. Palmer, Journal of Medicinal Chemistry Pharmaceutical ScienceOrganic ChemistryAntimicrobial ChemotherapyChemistryHeterocycle Chemistry	2011	109
Synthesis and Structure−activity Relationships of Antitubercular 2-Nitroimidazooxazines Bearing Heterocyclic Side Chains Hamish S. Sutherland, Adrian Blaser, Iveta Kmentová, Journal of Medicinal Chemistry HeterocyclicM. TuberculosisMedicineStructure−activity RelationshipsOrganic Chemistry	2009	89
Design, Synthesis, and Pharmacological Evaluation of Mefloquine‐Based Ligands as Novel Antituberculosis Agents Jialin Mao, Yuehong Wang, Baojie Wan, ChemMedChem Bioorganic ChemistryActive Hydrazone 10Antimicrobial ChemotherapyPharmaceutical ChemistryDrug Resistance	2007	83
The Oxidation-sensing Regulator (MosR) Is a New Redox-dependent Transcription Factor in Mycobacterium tuberculosis Pedro Brugarolas, Farahnaz Movahedzadeh, Yuehong Wang, Journal of Biological Chemistry Molecular BiologyRedox BiologyOxidation-sensing RegulatorOxidative StressTranscriptional Regulation	2012	83
Unbiased evaluation of bioactive secondary metabolites in complex matrices Taichi Inui, Yuehong Wang, Samuel M. Pro, Fitoterapia BiochemistryMedicineMetabolomic ProfilingSecondary MetaboliteUnbiased Evaluation	2012	78

Page 1